Literature DB >> 6789856

Binding of peanut lectin to germinal-centre cells: a marker for B-cell subsets of follicular lymphoma?

M L Rose, J A Habeshaw, R Kennedy, J Sloane, E Wiltshaw, A J Davies.   

Abstract

The binding of horseradish-peroxidase-labelled peanut lectin (HRP-PNL) to cryostat sections of tonsil, lymphoma lymph nodes, reactive lymph nodes and miscellaneous tumours demonstrated that PNL binds selectively to lymphocytes in germinal centres. Lymph nodes from 21 patients with non-Hodgkin's lymphomas were phenotyped as cell suspensions for PNL binding, and the following surface markers: E rosetting, C3d, SIg, OK markers of T-cell subsets, Ig heavy-chain and light-chain classes. There was a positive correlation between PNL binding and cells with SIg and C3d receptors. 4/5 cases of centroblastic/centrocytic follicular lymphoma had a PNL+ SIg+ C3d+ phenotype. Both cases of centroblastic/centrocytic diffuse lymphoma were PNL-. There was no correlation between PNL binding and heavy- or light-chain Ig class. PNL binding and presence of C3d receptors were not always positively correlated, indicating that follicular cells may be either PNL+ SIg+ C3d+ or PNL+ SIg+ C3d-. The binding pattern of PNL to 1 case of thymic hyperplasia and 2 cases of malignant lymphoma lymphoblastic T type suggested that some but not all cortical thymocytes bind PNL.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6789856      PMCID: PMC2010668          DOI: 10.1038/bjc.1981.149

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  9 in total

1.  Separation of mouse thymocytes into two subpopulations by the use of peanut agglutinin.

Authors:  Y Reisner; M Linker-Israeli; N Sharon
Journal:  Cell Immunol       Date:  1976-07       Impact factor: 4.868

2.  Immunochemical studies on the specificity of the peanut (Arachis hypogaea) agglutinin.

Authors:  M E Pereira; E A Kabat; R Lotan; N Sharon
Journal:  Carbohydr Res       Date:  1976-10       Impact factor: 2.104

3.  Expression of binding sites for peanut agglutinin during murine B lymphocyte differentiation.

Authors:  R A Newman; M A Boss
Journal:  Immunology       Date:  1980-06       Impact factor: 7.397

4.  Peanut agglutinin. II. Characterization of the Thy-1, Tla and Ig phenotype of peanut agglutinin-positive cells in adult, embryonic and nude mice using double immunofluorescence.

Authors:  G E Roelants; J London; K S Mayor-Withey; B Serrano
Journal:  Eur J Immunol       Date:  1979-02       Impact factor: 5.532

5.  Interaction of peanut agglutinin with normal human lymphocytes and with leukemic cells.

Authors:  Y Reisner; M Biniaminov; E Rosenthal; N Sharon; B Ramot
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

6.  Peanut agglutinin. I. A new tool for studying T lymphocyte subpopulations.

Authors:  J London; S Berrih; J F Bach
Journal:  J Immunol       Date:  1978-08       Impact factor: 5.422

7.  Binding of peanut lectin to thymic cortex and germinal centres of lymphoid tissue.

Authors:  M L Rose; F Malchiodi
Journal:  Immunology       Date:  1981-04       Impact factor: 7.397

8.  Peanut lectin binding properties of germinal centres of mouse lymphoid tissue.

Authors:  M L Rose; M S Birbeck; V J Wallis; J A Forrester; A J Davies
Journal:  Nature       Date:  1980-03-27       Impact factor: 49.962

9.  Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.

Authors:  J A Habeshaw; P F Catley; A G Stansfeld; R L Brearley
Journal:  Br J Cancer       Date:  1979-07       Impact factor: 7.640

  9 in total
  13 in total

1.  Magnetic-based purification of untouched mouse germinal center B cells for ex vivo manipulation and biochemical analysis.

Authors:  Matthew H Cato; Irene W Yau; Robert C Rickert
Journal:  Nat Protoc       Date:  2011-06-09       Impact factor: 13.491

2.  Differences in marker expression among branched histiocytic cells in T-cell areas of the lymphoreticular system and among their epidermis- and mucosa-associated equivalents.

Authors:  G Mechtersheimer; I Brandt; P Möller
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

3.  Two monoclonal antibodies raised against a Burkitt lymphoma cell line recognise different cell types within lymphoid follicles.

Authors:  L J Murray; S Dhut; L C Walker; M Rainey; J A Habeshaw
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

4.  Conspicuous enterocytic binding pattern for peanut lectin and malignant histiocytosis of the intestine.

Authors:  P Möller; B Schüle; U Römmele; M Hüpen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

5.  Lectin-binding spectra in the hyperplastic human tonsil. Effect of formalin fixation and paraffin embedding on lectin affinity of tissue components.

Authors:  R Wirbel; P Möller; K Schwechheimer
Journal:  Histochemistry       Date:  1984

6.  PNA-binding glycans are expressed at high levels on horse mature and immature T lymphocytes and a subpopulation of B lymphocytes.

Authors:  Catherine Mérant; Ali Messouak; Jean-Luc Cadoré; Jean-Claude Monier
Journal:  Glycoconj J       Date:  2005-02       Impact factor: 2.916

7.  Centrocytic lymphoma: a distinct clinicopathologic and immunologic entity. A multiparameter study of 18 cases at diagnosis and relapse.

Authors:  S H Swerdlow; J A Habeshaw; L J Murray; H S Dhaliwal; T A Lister; A G Stansfeld
Journal:  Am J Pathol       Date:  1983-11       Impact factor: 4.307

8.  Peanut lectin: a useful tool for detecting Hodgkin cells in paraffin sections.

Authors:  P Möller
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982-08

9.  Characteristics of Sternberg-Reed, and related cells in Hodgkin's disease: an immunohistological study.

Authors:  M S Dorreen; J A Habeshaw; A G Stansfeld; P F Wrigley; T A Lister
Journal:  Br J Cancer       Date:  1984-04       Impact factor: 7.640

10.  Studies of lectin binding to normal and neoplastic lymph nodes. II. Non-Hodgkin's lymphoma.

Authors:  V H Bramwell; D Crowther; J Gallagher; R W Stoddart
Journal:  Br J Cancer       Date:  1982-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.